Optimising corticosteroid treatment for autoimmune pancreatitis

Gut

Volumn 56, Issue 12, 2007, Pages 1650-1652

  Ghazale, Amaar ^a   Chari, Suresh T ^a,b  

^a Mayo Clinic   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN G4; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

ABDOMINAL PAIN; ALLERGIC REACTION; AUTOIMMUNE PANCREATITIS; BILE DUCT OBSTRUCTION; BONE MARROW SUPPRESSION; BONE NECROSIS; CATARACT; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; FOLLOW UP; HEADACHE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTERSTITIAL NEPHRITIS; LEUKOPENIA; LIVER TOXICITY; LOW DRUG DOSE; LYMPHOMA; NAUSEA; NOTE; OBSTRUCTIVE JAUNDICE; OSTEOPOROSIS; PANCREAS PSEUDOCYST; PANCREATITIS; PERIPHERAL EDEMA; PRIORITY JOURNAL; REMISSION; RETROPERITONEAL FIBROSIS; RHEUMATIC DISEASE; SCLEROSING CHOLANGITIS; TREATMENT OUTCOME;

ACUTE DISEASE; AUTOIMMUNE DISEASES; GLUCOCORTICOIDS; HUMANS; PANCREATITIS; RECURRENCE; TREATMENT OUTCOME;

EID: 36749038742     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.129833     Document Type: Note

References (16)

1. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38(10):982-4.
2. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the mayo clinic experience. Clin Gastroenterol Hepatol 2006;4(8):1010-16.
3. Kamisawa T, Yoshiike M, Egawa N, et al. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005;5(2-3):234-8; discussion 238-40.
4. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis without and with corticosteroid treatment. Gut 2007;56:1719-24.
5. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Eng J Med 2001;344(10):732-8.
6. Nishino T, Toki F, Oyama H, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005;30(1):76-82.
7. Kamisawa T, Egawa N, Nakajima H, et al. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol 2004;39(11):1154-8.
8. Zamboni G, Luttaes J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445(6):552-63.
9. Wakaboyashi T, Kawaura Y, Satomura Y, et al. Long-term prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment. Pancreas 2005;30(1):31-9.
10. Kamisawa T, Okamoto A. Prognosis of autoimmune pancreatitis. J Gastroenterol 2007;42(Suppl 18):59-62.
11. Kim KP, Kim MH, Song MH, et al. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004;99(8):1605-16.
12. Nishino T, Toki F, Oyama H, et al. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 2006;45(8):497-501.
13. Da Silva JA, Jacobs JW, Kirwan JR, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis 2006;65(3):285-93.
14. van Buuren HR, Vleggaar FP, Willemien Erkelens G, et al. Autoimmune pancreatocholangltis: a series of ten patients. Scand J Gastroenterol 2006;243:70-8.
15. Su C, Lichtenstein GR. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine. Gastroenterol Clin North Am 2004;33(2):209-34.
16. Wang K, Zhang H, Li Y, et al. Safely of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review. Transplant Proc 2004;36(7):2068-70.